Outlook Therapeutics's total assets for Q3 2026 were $26.18M, an increase of 19.61% from the previous quarter. DE:41O total liabilities were $36.58M for the fiscal quarter, a -28.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.